Investing.com UK - Financial Markets Worldwide
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Published 07/03/2024, 18:35
Updated 07/03/2024, 19:40
© Reuters. Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
HNRG
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.

HighPeak Energy posted GAAP earnings of 66 cents per share, versus market estimates of 65 cents per share. The company’s quarterly sales came in at $301.153 million versus expectations of $339.525 million.

HighPeak Energy shares declined 15.3% to $13.49 on Thursday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares jumped 404% to $11.65 after the company announced the launch of Lytus Cloud.
  • CERo Therapeutics Holdings, Inc. (NASDAQ: CERO) gained 167% to $6.81. CERo Therapeutics announced the publication in clinical cancer research a paper titled "Therapeutic Targeting of TIM-4-L With Engineered T CellsFor Acute Myeloid Leukemia."
  • Brera Holdings PLC (NASDAQ: BREA) shares climbed 97.5% to $2.0150 after the company announced that its Executive Chairman, Daniel McClory, acquired a majority stake in the company.
  • Grom Social Enterprises, Inc. (NASDAQ: GROM) gained 88.3% to $1.45. The company announced that it entered into a non-binding letter of intent to acquire Arctic7.
  • Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) rose 43% to $6.83. Creative Medical Technology announces FDA authorization for groundbreaking Type 1 diabetes prevention therapy under expanded access.
  • Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) gained 40.5% to $8.35 after the company received FDA Breakthrough Therapy Designation for its MM120 program in generalized anxiety disorder. The company also announced 12-week durability data from its Phase 2B study of MM120.
  • ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) jumped 34.2% to $2.1601 after the company announced that its subsidiary BioStrand developed a Foundation AI Model that uses Large Language Models Stacking and HYFT Technology.
  • Beneficient (NASDAQ: BENF) shares rose 28.7% to $0.1287. Beneficient agreed to the financing of liquidity transactions for three separate funds managed by ff Venture Capital.
  • MoneyLion Inc. (NYSE: ML) gained 28.3% to $67.43 following strong quarterly sales.
  • CompoSecure, Inc. (NASDAQ: CMPO) gained 27.5% to $5.99 as the company reported better-than-expected fourth-quarter financial results on Wednesday.
  • NexImmune, Inc. (NASDAQ: NEXI) rose 26% to $8.23.
  • Rush Street Interactive, Inc. (NYSE: RSI) gained 25.6% to $6.77 as the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for 2024.
  • OneSpan Inc. (NASDAQ: OSPN) climbed 24.9% to $11.97 after the company reported better-than-expected fourth-quarter financial results.
  • AirNet Technology Inc. (NASDAQ: ANTE) rose 24.7% to $1.51.
  • Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) climbed 23.2% to $41.35.
  • Ocean Biomedical, Inc. (NASDAQ: OCEA) gained 22.7% to $4.96.
  • Enhabit, Inc. (NASDAQ: EHAB) rose 21.9% to $9.58 following strong quarterly results.
  • Rentokil Initial plc (NYSE: RTO) gained 19.2% to $32.94 after the company reported better-than-expected FY23 financial results.
  • Wave Life Sciences Ltd. (NYSE: WVE) climbed 18.8% to $7.47. HC Wainwright & Co. analyst Andrew Fein maintained WAVE Life Sciences with a Buy and raised the price target from $8 to $15.
  • The Honest Company, Inc. (NASDAQ: HNST) rose 18.5% to $3.7301 after the company reported better-than-expected fourth-quarter financial results.
  • Dave Inc. (NYSE: DAVE) gained 18.2% to $37.38.
  • The Chemours Company (NYSE: CC) climbed 16.5% to $25.67.
  • Arhaus, Inc. (NASDAQ: ARHS) gained 15.2% to $14.77 following upbeat quarterly results.
  • AudioEye, Inc. (NASDAQ: AEYE) shares gained 13.8% to $7.89 after the company reported mixed fourth-quarter financial results and issued guidance.
  • Kronos Worldwide, Inc. (NYSE: KRO) climbed 13.5% to $9.82 following upbeat quarterly results.
  • Avangrid, Inc. (NYSE: AGR) gained 12.7% to $36.15 after the company announced that the Unaffiliated Committee of its Board of Directors received a non-binding proposal from Iberdrola to acquire all common shares that it or its affiliates do not own for $34.25 in cash per share.
  • E2open Parent Holdings, Inc. (NYSE: ETWO) gained 10.5% to $4.4750. E2open announced initiation of a strategic review.
  • Avinger, Inc. (NASDAQ: AVGR) shares rose 8.8% to $4.0252 after the company entered into strategic partnership and up to $15 million equity funding agreement with Zylox-Tonbridge to access Greater China market.
  • The Kroger Co. (NYSE: KR) gained 6.9% to $53.99 after the company reported fourth-quarter EPS above estimates.
  • Yext, Inc. (NYSE: YEXT) shares gained 6.1% to $6.32 after the company reported better-than-expected fourth-quarter financial results.
Losers
  • Solowin Holdings (NASDAQ: SWIN) fell 31.6% to $32.12 after jumping 135% on Wednesday.
  • MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) dipped 30.7% to $0.5266.
  • Victoria's Secret & Co. (NYSE: VSCO) dipped 30.1% to $17.90 after reporting fourth-quarter results.
  • Methode Electronics, Inc. (NYSE: MEI) fell 28.7% to $15.00 following weak quarterly results.
  • Nature Wood Group Limited (NASDAQ: NWGL) fell 27.1% to $13.60.
  • Aptorum Group Limited (NYSE: APM) shares fell 27.1% to $6.92. Aptorum shares jumped 468% on Wednesday after the company announced it entered into an agreement and plan of merger with YOOV and also announced a spin-off agreement to separate its legacy business.
  • Avid Bioservices, Inc. (NASDAQ: CDMO) shares fell 25.9% to $6.51 after the company reported certain preliminary third-quarter financial results and announced a proposed $160 million private placement of convertible notes.
  • Airship AI Holdings, Inc. (NASDAQ: AISP) fell 25.1% to $5.18. Airship AI Holdings filed amended S-1 registration statement.
  • CNFinance Holdings Limited (NYSE: CNF) fell 24.6% to $1.7559.
  • Emergent BioSolutions Inc. (NYSE: EBS) fell 21.5% to $2.56 after posting weak quarterly results.
  • Enviva Inc. (NYSE: EVA) shares tumbled 15.6% to $0.7950 after surging over 27% on Wednesday.
  • Viking Therapeutics, Inc. (NASDAQ: VKTX) fell 15% to $77.40. Jefferies analyst Roger Song initiated coverage on Viking Therapeutics with a Buy rating and announced a price target of $110.
  • Hudson Technologies, Inc. (NASDAQ: HDSN) fell 15% to $12.08 following fourth-quarter results.
  • Ciena Corporation (NYSE: CIEN) dipped 13.8% to $53.40 after the company reported first-quarter revenue decline.
  • TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) declined 13% to $9.46 after the company reported worse-than-expected fourth-quarter financial results.
  • Stevanato Group S.p.A. (NYSE: STVN) fell 10.3% to $29.70 following fourth-quarter results.
  • ADT Inc. (NYSE: ADT) shares fell 8.9% to $6.81 as the company reported pricing of secondary public offering of common stock and concurrent share repurchase.
Now Read This: How To Earn $500 A Month From Broadcom Ahead Of Q1 Earnings Report

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.